Genix Pharmaceuticals (TSE:GENX)
TSXV:GENX
Canadian Market

Genix Pharmaceuticals (GENX) Income Statement

1 Followers

Genix Pharmaceuticals Income Statement

Last quarter (Q2 2024), Genix Pharmaceuticals's total revenue was C$8.08K, a decrease of 0.00% from the same quarter last year. In Q2, Genix Pharmaceuticals's net income was C$-234.02K. See Genix Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Oct 23Oct 22Oct 21Oct 20Oct 19
Total Revenue
C$ 10.84KC$ 12.35K--C$ 0.00C$ 137.40K
Cost of Revenue
C$ 8.34KC$ 9.08K--C$ 0.00C$ 183.09K
Gross Profit
C$ 2.50KC$ 3.26K--C$ 0.00C$ -45.69K
Operating Expense
C$ 703.93KC$ 884.16KC$ 1.03MC$ 1.65MC$ 715.21KC$ 97.65K
Operating Income
C$ -701.44KC$ -880.89KC$ -1.03MC$ -1.65MC$ -715.21KC$ -143.34K
Net Non Operating Interest Income Expense
C$ -68.33KC$ -51.93KC$ -11.98KC$ 2.06KC$ -3.45KC$ -1.78K
Other Income Expense
C$ 3.46MC$ -3.46M-C$ 4.47KC$ -8.00C$ -19.59K
Pretax Income
C$ -4.23MC$ -4.40MC$ -1.07MC$ -1.65MC$ -718.66KC$ -164.70K
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
C$ -4.23MC$ -4.40MC$ -1.07MC$ -1.65MC$ -718.66KC$ -164.70K
Basic EPS
C$ -0.06C$ -0.07C$ -0.02C$ -0.03C$ -0.02C$ >-0.01
Diluted EPS
C$ -0.06C$ -0.07C$ -0.02C$ -0.03C$ -0.02C$ >-0.01
Basic Average Shares
C$ 236.90MC$ 59.22MC$ 59.22MC$ 59.22MC$ 49.96MC$ 37.51M
Diluted Average Shares
C$ 236.90MC$ 59.22MC$ 59.22MC$ 59.22MC$ 49.96MC$ 37.51M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
----C$ 177.00C$ 5.11K
Total Expenses
C$ 712.27KC$ 893.24KC$ 1.03MC$ -1.65MC$ 715.21KC$ 280.73K
Net Income From Continuing And Discontinued Operation
C$ -4.23MC$ -4.40MC$ -1.07MC$ -1.65MC$ -718.66KC$ -164.70K
Normalized Income
C$ 274.86KC$ 226.13KC$ -789.39KC$ -1.21MC$ -718.65KC$ -145.12K
Interest Expense
----C$ 3.88KC$ 1.78K
EBIT
C$ -4.16MC$ -4.34MC$ -1.06MC$ -1.65MC$ -714.78KC$ -162.92K
EBITDA
C$ -3.89MC$ -3.80MC$ -497.69KC$ -1.11MC$ -353.21KC$ -162.67K
Currency in CAD

Genix Pharmaceuticals Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis